Rare diseases
Investigational molecules
Locations
Im Ergel 1, 5404
Clinical research at Kantonsspital Baden AG includes studies in type II diabetes mellitus, with attention to patients whose glycaemic control remains insufficient despite standard antidiabetic treatment. The sponsor’s work in this area reflects a focus on improving metabolic control and reducing the burden of diabetes-related complications.
The diabetes portfolio is centred on therapeutic strategies that support better long-term blood glucose management in adult patients.
Kantonsspital Baden AG runs clinical trials in conditions such as Type 2 diabetes mellitus, Inflammation, Autoimmune disorder, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Belgium
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
